Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xaquin Castro Dopico

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Lancet. Infectious Diseases|March 20, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional studyDaniel J Sheward, Changil Kim, Roy A Ehling, et al.
Nucleic Acids Research|January 11, 2023
Translation initiation of leaderless and polycistronic transcripts in mammalian mitochondriaCristina Remes, Anas Khawaja, Sarah F Pearce, et al.
Cell Reports|January 16, 2025
Antigen affinity and site of immunization dictate B cell recall responsesManon Termote, Rafael C Marques, Erik Hyllner, et al.
The Journal of Infectious Diseases|March 21, 2021
Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological SymptomsJanet L Cunningham, Johan Virhammar, Bengt Rönnberg, et al.
Cell Reports. Medicine|November 1, 2021
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal modelsDaniel J Sheward, Marco Mandolesi, Egon Urgard, et al.
Cell Reports. Medicine|April 12, 2021
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responsesMarco Mandolesi, Daniel J Sheward, Leo Hanke, et al.
Immunity|December 27, 2022
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodiesPradeepa Pushparaj, Andrea Nicoletto, Daniel J Sheward, et al.
Diabetologia|February 6, 2015
IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patientsRicardo C Ferreira, Henry Z Simons, Whitney S Thompson, et al.
Nature Communications|May 13, 2015
Widespread seasonal gene expression reveals annual differences in human immunity and physiologyXaquin Castro Dopico, Marina Evangelou, Ricardo C Ferreira, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|March 20, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional studyDaniel J Sheward, Changil Kim, Roy A Ehling, et al.
Nucleic Acids Research|January 11, 2023
Translation initiation of leaderless and polycistronic transcripts in mammalian mitochondriaCristina Remes, Anas Khawaja, Sarah F Pearce, et al.
Cell Reports|January 16, 2025
Antigen affinity and site of immunization dictate B cell recall responsesManon Termote, Rafael C Marques, Erik Hyllner, et al.
The Journal of Infectious Diseases|March 21, 2021
Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological SymptomsJanet L Cunningham, Johan Virhammar, Bengt Rönnberg, et al.
Cell Reports. Medicine|November 1, 2021
Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal modelsDaniel J Sheward, Marco Mandolesi, Egon Urgard, et al.
Cell Reports. Medicine|April 12, 2021
SARS-CoV-2 protein subunit vaccination of mice and rhesus macaques elicits potent and durable neutralizing antibody responsesMarco Mandolesi, Daniel J Sheward, Leo Hanke, et al.
Immunity|December 27, 2022
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodiesPradeepa Pushparaj, Andrea Nicoletto, Daniel J Sheward, et al.
Diabetologia|February 6, 2015
IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patientsRicardo C Ferreira, Henry Z Simons, Whitney S Thompson, et al.
Nature Communications|May 13, 2015
Widespread seasonal gene expression reveals annual differences in human immunity and physiologyXaquin Castro Dopico, Marina Evangelou, Ricardo C Ferreira, et al.
Clinical & Translational Immunology|March 14, 2022
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimatesXaquin Castro Dopico, Sandra Muschiol, Nastasiya F Grinberg, et al.
Pageof 4